Table 1.
Summary of the studies included in the analysis.
| Characteristic | N = 5585 | Study Information |
|---|---|---|
| Study | ||
| CACTI | 19 (0.34%) | Adults with type 1 diabetes |
| CADPredictions | 147 (2.63%) | Adults with acute coronary syndromes |
| CardioRen | 116 (2.08%) | Adults with heart failure with reduced ejection fraction |
| DIRECT | 769 (13.77%) | Adults with type 2 diabetes with normoalbuminuria |
| EPOGH | 826 (14.79%) | Adults with type 2 diabetes treated with basal insulin |
| FLEMENGHO | 65 (1.16%) | General population |
| Generation Scotland | 450 (8.06%) | Adults with and without coronary artery disease (CAD) |
| HOMAGE | 354 (6.34%) | Adults with heart failure |
| Predictions Groningen_Prag | 38 (0.68%) | Adults with type 2 diabetes |
| PRIORITY | 1761 (31.53%) | Adults with type 2 diabetes, normal urinary albumin excretion, and preserved renal function |
| SUNmacro | 580 (10.38%) | Adults with type 2 diabetic nephropathy |
| UZ-Gent | 460 (8.24%) | Adults with chronic kidney disease |
| n (%) | ||